Enzymes in the Dissolution Testing of Gelatin Capsules

Ageing International

Volumn 15, Issue 6, 2014, Pages 1410-1416

  Marques, Margareth R C ^a  

^a UNITED STATES PHARMACOPEIA   (United States)

Author keywords

cross linking; gelatin capsules; two tier dissolution testing

Indexed keywords

BROMELAIN; CROSS LINKING REAGENT; GELATIN; MICROCAPSULE; PANCREATIN; PAPAIN; PEPSIN A; PEPTIDE HYDROLASE;

CHEMISTRY; KINETICS; MICROCAPSULE; PH; PHARMACEUTICS; PROCEDURES; REPRODUCIBILITY; SOLUBILITY; STANDARDS;

BROMELAINS; CAPSULES; CROSS-LINKING REAGENTS; GELATIN; HYDROGEN-ION CONCENTRATION; KINETICS; PANCREATIN; PAPAIN; PEPSIN A; PEPTIDE HYDROLASES; REPRODUCIBILITY OF RESULTS; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL;

EID: 84912117845     PISSN: 01635158     EISSN: 1936606X     Source Type: Journal    
DOI: 10.1208/s12249-014-0162-3     Document Type: Article

References (35)

1. Marques MRC, Cole E, Kruep D, Gray V, Murachanian D, Brown WE, et al. Liquid-filled gelatin capsules. Pharm Forum. 2009;35(4). www.usppf.com.
2. Podczeck F, Jones BE. Pharmaceutical capsules. London: Pharmaceutical Press; 2004.
3. Hu J, Kyad A, Ku V, Zhou P, Cauchon N. A comparison of dissolution testing on lipid soft gelatin capsules using USP apparatus 2 and apparatus 4. Dissol Technol. 2005;12(2):6–9.
4. Meyer MC, Strughn AB, Mhatre RM, Hussain A, Sha VP, Bottom CB, et al. The effect of gelatin cross-linking on the bioequivalence of hard and soft gelatin acetaminophen capsules. Pharm Res. 2000;17(8):962–6.
5. Chang CK, Alvarez-Nunez FA, Rinella Jr JV, Magnusson LE, Sued K. Roller compaction, granulation and capsule product dissolution of drug formulations containing a lactose or mannitol filler, starch, and talc. AAPS PharmSciTech. 2008;9(2):597–604.
6. Elmeshad AN, Darwish MK. Stability studies of the effect of crosslinking on hydrochlorothiazide release. Drug Discov Ther. 2009;3(3):136–42.
7. St. Clair MJ, Purdie J, Hu Y, McGeough P. The effect of cross-linking on the in vitro disintegration of hard gelatin capsules. J Pharm Pharmacol. 2010;62(10):1235–6.
8. USP. USP 36 – NF 31. <711 > Dissolution. Rockville: US Pharmacopeial Convention; 2013. p. 307.
9. <1094 > Capsules—dissolution testing and related quality attributes. Pharm Forum. 2013;39(3). www.usppf.com.
10. Cole ET, Cade D, Benameur H. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration. Adv Drug Deliv Rev. 2008;60:747–56.
11. Rose PI. Gelatin. In: The theory of the photographic process. 4th ed. New York: Macmillan Publ. Co.; 1977. p. 51–67.
12. Kalantzi L, Page R, Nicolaides E, Digenis G, Reppas C. In vitro methods can forecast the effects of intragastric residence on dosage form performance. Eur J Pharm Sci. 2008;33:445–51.
13. Jones BE. How gelatin and hypromellose capsules differ in product release during dissolution testing. Tablets & Capsules. 2010; January: 16–19.
14. Aikman M et al. Collaborative development of two-tier dissolution testing for gelatin capsules and gelatin-coated tablets using enzyme-containing media. Pharm Forum. 1998;24(5):704–7050.
15. USP. USP 24 – NF 19, First supplement. <711 > Dissolution. Rockville: US Pharmacopeial Convention; 2000. p. 2696
16. Singh S, Rao KVR, Venugopal K, Manikandan R. Alteration in dissolution characteristics of gelatin-containing formulations. Pharm Technol. 2002;26:36–58.
17. Tengroth C, Gasslander U, Anderson FO, Jacobsson SP. Cross-linking of gelatin capsules with formaldehyde and other aldehydes: an FTIR spectroscopy study. Pharm Dev Technol. 2005;10:405–12.
18. Song X, Cui Y, Xie M. Gelatin capsule shell cross-linking. Tier II dissolution method development in the presence of sodium lauryl sulfate. Pharm Technol. 2011;35(5):62–8.
19. Piper DW, Fenton BH. pH stability and activity curves of pepsin with special reference to their clinical importance. Gut. 1965;6:506–8.
20. USP. USP 36 – NF 31. Purified pepsin. Rockville: US Pharmacopeial Convention; 2013. p. 1181.
21. Kristo K, Pintye-Hodi K. Effects of pharmaceutical processing on pepsin activity during the formulation of solid dosage forms. Pharm Dev Technol. 2013;18(1):17–21.
22. Berdutina AV, Neklyudov AD, Ivankin AI, Karpo BS, Mitaleva SI. Comparison of proteolytic activities of the enzyme complex from mammalian pancreas and pancreatin. Appl Biochem Microbiol. 2000;36:363–7.
23. USP. USP 36 – NF 31. Pancreatin. Rockville: US Pharmacopeial Convention; 2013. p. 4672.
24. Azarkan M, El Moussaoui A, van Wuytswinkel D, Dehon G, Looze Y. Fractionation and purification of the enzymes stored in the latex of Carica papaya. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;790(1–2):229–38.
25. Arnon R. Papain. In: Perlmann G, Lorand L, editors. Method in enzymology, vol. 19. New York: Academic; 1970. p. 226–45.
26. Kimmel JR, Smith EL. The properties of papain. In: Nord FF, editor. Advances in enzymology and related areas of molecular biology, vol. 19. New York: Interscience Publ; 1957. p. 267–333.
27. Lineweaver H, Schwimmer S. Some properties of crystalline papain. Enzymologia. 1941;10:81–6.
28. Hoover SR, Kokes ELC. Effect of pH upon proteolysis by papain. J Biol Chem. 1947;167(1):199–207.
29. USP. USP 36 – NF 31. Papain. Rockville: US Pharmacopeial Convention; 2013. p. 4186.
30. Corzo CA, Waliszewski KN, Welti-Chanes J. Pineapple fruit bromelain affinity to different protein substrates. Food Chem. 2012;133(3):631–5.
31. Lu X, Xiao B, Lo L, Bolgar MS, Lloyd DK. Development of a two-step tier-2 dissolution method for blinded overencapsulated erlotinib tablets using UV fiber optic detection. J Pharm Biomed Anal. 2011;56:23–9.
32. Pennings FH, Kwee BLS, Vromans H. Influence of enzymes and surfactants on the disintegration behavior of cross-linked hard gelatin capsules during dissolution. Drug Dev Ind Pharm. 2006;32:33–7.
33. USP. USP 36 – NF 31. The dissolution procedure: development and validation <1092>, Rockville: US Pharmacopeial Convention; 2013. p. 735.
34. Gallery J, Han JH, Abraham C. Pepsin and pancreatin performance in the dissolution of crosslinked gelatin capsules from pH 1 to 8. Pharm Forum. 2004;30(3):1084–1089. www.usppf.com.
35. Bottom CB, Clark M, Carstensen JT. Dissolution testing of soft shell capsules—acetaminophen and nifedipine. J Pharm Sci. 1997;86(9):1057–61.